Izumi Wasada

626 total citations
11 papers, 346 citations indexed

About

Izumi Wasada is a scholar working on Oncology, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Izumi Wasada has authored 11 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Pathology and Forensic Medicine and 3 papers in Hematology. Recurrent topics in Izumi Wasada's work include Lymphoma Diagnosis and Treatment (6 papers), Viral-associated cancers and disorders (4 papers) and Immune Cell Function and Interaction (3 papers). Izumi Wasada is often cited by papers focused on Lymphoma Diagnosis and Treatment (6 papers), Viral-associated cancers and disorders (4 papers) and Immune Cell Function and Interaction (3 papers). Izumi Wasada collaborates with scholars based in Japan. Izumi Wasada's co-authors include Tomomitsu Hotta, Kenichi Ishizawa, Kensei Tobinai, Kazuo Oshimi, Motoko Yamaguchi, Masahiko Oguchi, Yoshihiro Matsuno, Yukio Kobayashi, Yoshikazu Kagami and Kuniaki Itoh and has published in prestigious journals such as Journal of Clinical Oncology, Blood and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Izumi Wasada

10 papers receiving 333 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Izumi Wasada Japan 7 263 243 126 41 40 11 346
Rafael Dezen Gaiolla Brazil 8 218 0.8× 187 0.8× 124 1.0× 34 0.8× 11 0.3× 20 362
Kevin Tay Singapore 11 187 0.7× 164 0.7× 101 0.8× 31 0.8× 25 0.6× 22 321
Bertrand Joly France 8 199 0.8× 157 0.6× 45 0.4× 40 1.0× 17 0.4× 25 257
Lilj Uziel Italy 7 247 0.9× 133 0.5× 32 0.3× 130 3.2× 18 0.5× 12 356
Arif Alam United Arab Emirates 9 162 0.6× 133 0.5× 70 0.6× 31 0.8× 19 0.5× 26 333
Zdravko Mitrović Croatia 10 160 0.6× 117 0.5× 51 0.4× 29 0.7× 8 0.2× 30 255
Annalisa Arcari Italy 11 159 0.6× 166 0.7× 20 0.2× 57 1.4× 23 0.6× 24 272
Soon-Thye Lim Singapore 6 235 0.9× 193 0.8× 60 0.5× 59 1.4× 16 0.4× 8 280
Jill Davison Australia 7 116 0.4× 96 0.4× 62 0.5× 8 0.2× 11 0.3× 9 241
C Österreicher Austria 7 209 0.8× 115 0.5× 32 0.3× 45 1.1× 153 3.8× 9 321

Countries citing papers authored by Izumi Wasada

Since Specialization
Citations

This map shows the geographic impact of Izumi Wasada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Izumi Wasada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Izumi Wasada more than expected).

Fields of papers citing papers by Izumi Wasada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Izumi Wasada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Izumi Wasada. The network helps show where Izumi Wasada may publish in the future.

Co-authorship network of co-authors of Izumi Wasada

This figure shows the co-authorship network connecting the top 25 collaborators of Izumi Wasada. A scholar is included among the top collaborators of Izumi Wasada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Izumi Wasada. Izumi Wasada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Kawada, Hiroshi, Masakazu Sawanobori, Izumi Wasada, et al.. (2014). Phase I Clinical Trial of Intravenous L-ascorbic Acid Following Salvage Chemotherapy for Relapsed B-cell non-Hodgkin's Lymphoma.. PubMed. 39(3). 111–5. 15 indexed citations
2.
Yamaguchi, Motoko, Katsuyoshi Takata, Tadashi Yoshino, et al.. (2014). Prognostic biomarkers in patients with localized natural killer/T‐cell lymphoma treated with concurrent chemoradiotherapy. Cancer Science. 105(11). 1435–1441. 15 indexed citations
3.
Wasada, Izumi, Yuko Saito, Takashi Seto, et al.. (2013). Anemia affects the quality of life of Japanese cancer patients.. PubMed. 38(1). 7–11. 11 indexed citations
4.
Yamaguchi, Motoko, Kensei Tobinai, Masahiko Oguchi, et al.. (2012). Long-term follow-up results of a phase I/II study of concurrent chemoradiotherapy for localized nasal NK/T-cell lymphoma (NKTCL): JCOG0211.. Journal of Clinical Oncology. 30(15_suppl). 8050–8050.
5.
Seto, Takashi, Takeharu Yamanaka, Izumi Wasada, et al.. (2010). Phase I/II trial of gemcitabine plus oral TS-1 in elderly patients with advanced non-small cell lung cancer: Thoracic oncology research group study 0502. Lung Cancer. 69(2). 213–217. 9 indexed citations
6.
Yamaguchi, Motoko, Kensei Tobinai, Masahiko Oguchi, et al.. (2009). Phase I/II Study of Concurrent Chemoradiotherapy for Localized Nasal Natural Killer/T-Cell Lymphoma: Japan Clinical Oncology Group Study JCOG0211. Journal of Clinical Oncology. 27(33). 5594–5600. 244 indexed citations
7.
Tobinai, Kensei, Masahiko Oguchi, Yasushi Isobe, et al.. (2009). Phase I/II study of concurrent chemoradiotherapy for localized nasal NK/T-cell lymphoma: Final results of JCOG0211. Journal of Clinical Oncology. 27(15_suppl). 8549–8549. 4 indexed citations
8.
Oguchi, Masahiko, Yoshikazu Kagami, Satoshi Ishikura, et al.. (2008). Upfront Radiotherapy with Concurrent Chemotherapy for Localized Nasal NK/T-Cell Lymphoma: Radiotherapy Quality Assurance (QA) Review in Japan Clinical Oncology Group (JCOG) Trial 0211. International Journal of Radiation Oncology*Biology*Physics. 72(1). S474–S474. 2 indexed citations
9.
Shimozuma, Kojiro, Satoshi Morita, Kenichi Ishizawa, et al.. (2006). Clinical validity of the Japanese version of the Functional Assessment of Cancer Therapy-Anemia Scale. Supportive Care in Cancer. 15(1). 1–6. 5 indexed citations
10.
Ando, Kiyoshi, Satoshi Morita, Takahiro Higashi, et al.. (2006). Health-Related Quality of Life Among Japanese Women With Iron-Deficiency Anemia. Quality of Life Research. 15(10). 1559–1563. 34 indexed citations
11.
Yamaguchi, Motoko, Masahiko Oguchi, Kensei Tobinai, et al.. (2005). Phase I/II Study of Concurrent Chemoradiotherapy for Newly-Diagnosed, Localized Nasal NK/T-Cell Lymphoma: Results of a Phase I Portion of JCOG0211-DI.. Blood. 106(11). 2685–2685. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rafael Dezen Gaiolla Breakdown of academic impact, for papers by Kevin Tay Breakdown of academic impact, for papers by Bertrand Joly Breakdown of academic impact, for papers by Lilj Uziel Breakdown of academic impact, for papers by Arif Alam Breakdown of academic impact, for papers by Zdravko Mitrović Breakdown of academic impact, for papers by Annalisa Arcari Breakdown of academic impact, for papers by Soon-Thye Lim Breakdown of academic impact, for papers by Jill Davison Breakdown of academic impact, for papers by C Österreicher
Rankless by CCL
2026